Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 18, 2022

SELL
$32.83 - $38.63 $13,132 - $15,452
-400 Reduced 5.06%
7,500 $289,000
Q2 2018

Nov 18, 2022

BUY
$26.84 - $34.32 $10,736 - $13,728
400 Added 5.33%
7,900 $258,000
Q1 2018

Nov 18, 2022

BUY
$25.2 - $28.54 $189,000 - $214,050
7,500 New
7,500 $205,000
Q4 2017

Nov 18, 2022

SELL
$24.79 - $29.8 $185,925 - $223,500
-7,500 Closed
0 $0
Q2 2017

Nov 18, 2022

BUY
N/A
7,500 New
7,500 $208,000
Q3 2016

Nov 18, 2022

SELL
N/A
-10,000 Closed
0 $0
Q3 2015

Nov 18, 2022

SELL
N/A
-10,465 Reduced 51.14%
10,000 $164,000
Q2 2015

Nov 18, 2022

SELL
N/A
-7,035 Reduced 25.58%
20,465 $362,000
Q4 2014

Nov 18, 2022

SELL
N/A
-17,500 Reduced 38.89%
27,500 $364,000
Q3 2014

Nov 18, 2022

SELL
N/A
-20,000 Reduced 30.77%
45,000 $531,000
Q4 2012

Nov 18, 2022

BUY
N/A
65,000
65,000 $372,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Citizens Business Bank Portfolio

Follow Citizens Business Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Business Bank, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Business Bank with notifications on news.